Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_assertion type Assertion NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_head.
- NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_assertion description "[The mean survival time of the patients with cancers that lost Bcl-X(L) following CRT was significantly longer compared to those with cancers expressing Bcl-X(L).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_provenance.
- NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_assertion evidence source_evidence_literature NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_provenance.
- NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_assertion SIO_000772 18580065 NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_provenance.
- NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_assertion wasDerivedFrom befree-20140225 NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_provenance.
- NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_assertion wasGeneratedBy ECO_0000203 NP823429.RAsm1W6Z_fv78H7HBgUp0E6aaLS-ipvjTtrRoUVS44Ud8130_provenance.